Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Bayer and collaborators describe new EGFR inhibitors

Oct. 25, 2021

Researchers identify new GPR52 agonists

Oct. 22, 2021

Enyo Pharma presents ICD inducers

Oct. 22, 2021

Takeda Pharmaceutical synthesizes new somatostatin SST4 receptor agonists

Oct. 22, 2021

Merck & Co. divulges new coagulation factor XIa inhibitors

Oct. 22, 2021

Fujifilm patents HDAC6 inhibitors

Oct. 22, 2021

Medshine Discovery describes new compounds for cancer

Oct. 21, 2021

Dongguan Hec New Drug Research and Development synthesizes new HBV antivirals

Oct. 21, 2021

Angiex presents new TM4SF1-targeting PROTACs

Oct. 21, 2021

Chinese researchers disclose new ROS inhibitors

Oct. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...